Last Updated: September 28, 2026

Pharmobedient Cnsltg Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PHARMOBEDIENT CNSLTG

PHARMOBEDIENT CNSLTG has fifteen approved drugs.

Summary for Pharmobedient Cnsltg

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	15

Drugs and US Patents for Pharmobedient Cnsltg

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmobedient Cnsltg	PREDNISOLONE SODIUM PHOSPHATE	prednisolone sodium phosphate	SOLUTION;ORAL	075099-001	Jun 28, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Pharmobedient Cnsltg	CYCLOSPORINE	cyclosporine	SOLUTION;ORAL	065133-001	Sep 17, 2004		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Pharmobedient Cnsltg	LEVETIRACETAM	levetiracetam	SOLUTION;ORAL	090028-001	Mar 3, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Pharmobedient Cnsltg	DEXAMETHASONE	dexamethasone	ELIXIR;ORAL	088254-001	Jul 27, 1983		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Pharmobedient Cnsltg	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	062825-001	Oct 23, 1987		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Pharmobedient Cnsltg	CHOLESTYRAMINE LIGHT	cholestyramine	POWDER;ORAL	209599-001	Nov 12, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.